Información del producto
- Bm-13.1258
- 5-({4-[2-(5-Methyl-2-Phenyl-1,3-Oxazol-4-Yl)Ethoxy]-1-Benzothiophen-7-Yl}Methyl)-1,3-Thiazolidine-2,4-Dione
Edaglitazone is a drug used for the treatment of type 2 diabetes. It belongs to the class of thiazolidinedione drugs, which are insulin sensitizers. Edaglitazone has shown anti-inflammatory properties and may be useful in treating inflammatory diseases such as rheumatoid arthritis. This drug can also be used as a diagnostic tool to measure insulin sensitivity in humans by measuring erythrocyte glucose uptake. Edaglitazone has been shown to inhibit tumor growth and induce apoptosis in cancer cells, but not healthy cells, in animal models.
Propiedades químicas
Consulta técnica sobre: 3D-NIA41183 Edaglitazone
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
